Huston E, Scott R H, Dolphin A C
Department of Pharmacology, St George's Hospital Medical School, London, U.K.
Neuroscience. 1990;38(3):721-9. doi: 10.1016/0306-4522(90)90065-c.
Glutamate release has been examined from cultured cerebellar granule neurons in the rat using the technique of prelabelling the releasable pool of glutamate with [3H]glutamine. Glutamate release was stimulated in control neurons by 2-min incubation with 50 mM K+, or in neurons continuously depolarized in Ca2(+)-free 50 mM K+ medium, by 2-min incubation with medium containing 5 mM Ca2+. The ability of the Ca2(+)-channel agonist (+)-202-791 to increase the stimulated release of [3H]glutamate was approximately doubled in the depolarized condition. The antagonist enantiomer (-)-202-791 produced a small inhibition of K(+)-stimulated release, whereas (-)-202-791 completely inhibited Ca2(+)-stimulated release from depolarized neurons at concentrations greater than 10 nM. (-)-Baclofen (100 microM) inhibited transmitter release similarly (25-30%) under the two conditions. Calcium-channel currents were recorded from cultured dorsal root ganglion neurons under control conditions at a holding potential of -80 mV, or in neurons depolarized to -30 mV. (-)-202-791 produced a greater effect at -30 than at -80 mV although even at -30 mV the inhibition was slow in onset and incomplete. (-)-Baclofen (100 microM) inhibited the amplitude of the calcium-channel current at both holding potentials by 30-50%, although it did not clearly slow activation of the current at the depolarized holding potential. The GABAB receptors associated with inhibition of glutamate release and of calcium-channel currents were both markedly blocked by phaclofen but not by 2-OH-saclofen. These findings suggest that the GABAB receptor associated with inhibitory modulation of transmitter release, and that associated with inhibition of calcium-channel currents show pharmacological similarities, and are able to exert their action even at levels of steady depolarization at which most N-type channels should be inactivated.
利用用[³H]谷氨酰胺预标记可释放谷氨酸池的技术,已对大鼠培养的小脑颗粒神经元的谷氨酸释放进行了研究。在对照神经元中,通过与50 mM K⁺孵育2分钟来刺激谷氨酸释放,或者在无Ca²⁺的50 mM K⁺培养基中持续去极化的神经元中,通过与含5 mM Ca²⁺的培养基孵育2分钟来刺激谷氨酸释放。Ca²⁺通道激动剂(+)-202 - 791增加[³H]谷氨酸刺激释放的能力在去极化条件下约增加一倍。拮抗剂对映体(-)-202 - 791对K⁺刺激的释放有轻微抑制作用,而当浓度大于10 nM时,(-)-202 - 791完全抑制去极化神经元中Ca²⁺刺激的释放。(-)-巴氯芬(100 μM)在两种条件下对递质释放的抑制作用相似(25 - 30%)。在对照条件下,在-80 mV的钳制电位下,或在去极化至-30 mV的神经元中,记录培养的背根神经节神经元的钙通道电流。(-)-202 - 791在-30 mV时比在-80 mV时产生更大的作用,尽管即使在-30 mV时,抑制作用起效缓慢且不完全。(-)-巴氯芬(100 μM)在两个钳制电位下均使钙通道电流幅度抑制30 - 50%,尽管它在去极化钳制电位下并未明显减慢电流的激活。与谷氨酸释放抑制和钙通道电流抑制相关的GABAB受体均被法氯芬明显阻断,但未被2 - OH - 巴氯芬阻断。这些发现表明,与递质释放抑制性调节相关的GABAB受体以及与钙通道电流抑制相关的GABAB受体在药理学上具有相似性,并且即使在大多数N型通道应失活的稳定去极化水平下也能够发挥其作用。